Sarepta Therapeutics Inc. (NASDAQ:SRPT)

Bands Volume 200 SMA 50 SMA 20 SMA Videos Alerts Articles Events
SRPT Weekly Chart

Old Forum Content for SRPT

Make a Forum Post
Become a member to view recent forum posts. Already a member? Sign in here.
  • woodman: $SRPT continuing to move back up following its successful test of support last Friday.
  • woodman: $SRPT - working on a move back up.
  • sierramp: @woodman $SRPT Thanks for mentioning this. Their rev growth rate is astounding. Because of their many alliances and licensing agreements do you think they are less likely to be a TO target?
  • woodman: @sierramp $SRPT - I think it's a potential target because of its gene editing. But many are "'potential" targets. Beyond buyout speculation, however, I think it's one to own and hang on to.
  • woodman: Some for the "of interest" list: $ISRG $SQ $SRPT $NOAH $SPR $IPGP $ABMD
  • traderbren: $SRPT - new high.
  • woodman: $SRPT remains on fire. Gene therapy for muscular distrophy.
  • Sher: Continuing to take profits on long call positions: $WBA (62% - 2-day trade); $SRPT (STC @ HOD) – Getting out of the way of phase 2 PB – Stock now down 2.3%. Reigning in my comfort level, position and risk-wise – Excessive number of open call positions - Also took profits on $ESRX, $CENX, $JBLU, $TECK, $TRTN $TWTR & $XLE calls, Friday.
  • woodman: @gwenzee $JUNO $RXDX #Biotech $BLUE up ~7% in the afterhours. Biotech will jump tomorrow. Fwiw, GS sees these as having the highest M&A probability in biopharma (some of these are perennial buyout names): $AVXS $SAGE $SRPT $BMRN $BLUE $BMPC $CLVS $INCY $IPXL $PCRX $PTLA $ACAD $GWPH $BMY $IRWD $AGIO $ALKS $JUNO $SGEN $MNTA $BIVV.
  • gwenzee: @woodman $JUNO $RXDX $BLUE $AVXS $SAGE $SRPT $BMRN $BMPC $CLVS $INCY $IPXL $PCRX $PTLA $ACAD $GWPH $BMY $IRWD $AGIO $ALKS $SGEN $MNTA $BIVV #Biotech Thanks for the info. Previously held JUNO, BLUE, SRPT. Currently hold only INCY.
  • woodman: @gwenzee $ABMD $ONCE #Biotech- my current biotechs are $HALO $ESPR $SRPT $BLUE and, recently on the pullback, $JUNO.
  • gwenzee: @woodman $ABMD $ONCE $HALO $ESPR $SRPT $BLUE $JUNO #Biotech- You are doing well, my friend. Had SRPT and JUNO and BLUE at one time. Sold all and never bought back in. Today I'm holding ABMD, $CYRX, $OMER, $ONCE $INCY and $PBYI. Some of these look like an E-ride at Disneyland. Hope springs eternal.
  • woodman: @gwenzee $ABMD $ONCE $HALO $ESPR $SRPT $BLUE $JUNO $CYRX $OMER $INCY $PBYI #Biotech- PBYI may be coming to life again. I can't figure out INCY, but, fwiw, it's pulled all the way back to the 200 week. Maybe it will start to play nicely again. I'll send you some positive vibes. :-)
  • gwenzee: @woodman $ABMD $ONCE $HALO $ESPR $SRPT $BLUE $JUNO $CYRX $OMER $INCY $PBYI #Biotech- In the past had made some good $$$ on INCY. It is an old friend who has forgotten me. It still has a great pipeline and there has got to be a pony in there some place.
  • Sher: $TWTR – Took advantage of this morning’s 250% pop in Jan. $25 calls and exited with a profit – Position had been severely underwater, so grateful to be out ahead of OP EX… Still long stock. Also took money off the table in $ESRX, $CENX, $JBLU, $TECK, $TRTN & $XLE. $GBX – BTO Mar. $50 calls @ $3.30… $SRPT – BTO April $60 calls @ $6.75, EOD, yesterday…
  • traderbren: $SRPT -- looks constructive based on today's move. NP.
  • woodman: $SRPT - #Biotech is weak today, but this may be an okay spot to take a chance on $SRPT. The 50 day has been a good place for this one, though the past the tests of the 50 day have been at the bottom BB as well. That is lacking here. Still, perhaps for consideration if you've had an interest in it. I do have some that I've just been holding the last couple of months or so.
  • Bridget: $SRPT is at a good buy point. Coming off the 50dMA after a nice pullback and consolidation.
  • woodman: $SRPT $RXDX - collecting themselves at their rising 50 days.
  • woodman: $SRPT good spot.
  • vblegacy: @woodman $SRPT Started a position, but wish it had more vol.
  • woodman: $Biotech is getting smacked around but $SRPT is at a fairly low risk spot holding - for now - the 50 day.
  • woodman: @captron $SGMO - Thanks. Yes, at one point I did have an interest. No position at this time. I have only two biotechs right now -- $SRPT and $BLUE -- and I am trying to keep myself to holding a rather minimal number of them at any one time. Some day, I will likely buy $DVAX back, which by the way is bouncing off the 100 day today.
  • bRobert: $SRPT breakout . nh
  • woodman: @bRobert $SRPT Sarepta Therapeutics and Nationwide Children’s Hospital Announce FDA Clearance of IND for Micro-Dystrophin Gene Therapy Program for the Treatment of Duchenne Muscular Dystrophy
  • DrScience: $SRPT to new 52-week high on the strength of FDA gene therapy clearance. Biotech ($IBB, $XBI) leading as Healthcare ($XLV) is top market sector this morning. Financials ($XLF) taking the backseat.
  • woodman: $SRPT $ARRY $CLVS $FOLD in #Biotech land. Possibly $EXEL and $SGYP as well.
  • woodman: $SRPT swooping up.
  • Vehid: $SRPT is up premarket on news. Do you expect short squeeze with 6 days to cover? Thanks
  • DAN: @Vehid $SRPT Nope. It's a short.
  • JBed: $SRPT Buyout rumors, lots of momo rhrn. In it for a day trade.
  • bRobert: $SRPT .$GLD SRPT Blew past earnings yesterday. 25% short interest. Tight weekly squeeze breakout. GLD GDX . Continuing to run. Dollar sinking. LONG calls
  • bRobert: $GBT . $SRPT GBT tight squeeze SRPT short squeeze continues
  • woodman: $SRPT -
  • TRICIA: $SRPT- Sarepta Therapeutics Secures $100 Million in Debt Financing
  • traderbren: $SRPT - back above the 50dma, seeing interest.
  • justinp: $SRPT. Dropped below the 50sma. Have given this one enough rope and will probably kick to curb shortly.
  • genki: @justinp $SRPT Yes, but still above huge support and range-bound.
  • justinp: @woodman $AUPH Right, along with $LGND and $SRPT I'm being patient but trusting to stops.....
  • woodman: @debeers $MZOR - You were in $CARA and $SRPT and $MDVN. You were taking all their drugs?
  • debeers: @woodman $MZOR $CARA $SRPT $MDVN -$SRPT and $MDVN came to me through Gwenzee. $CARA was originally a Trisha stock wayback when,. I trust them and their due dil. The biggest wins were in $MDVN and the first $SRPT pop after the ruling for the parents. I should ;learn by now never to say never and thanks Woodie for reminding me!
  • spmeyers: $SRPT 200-day didn't hold on pull back; maybe the 20-day will
  • Sher: @spmeyers $SRPT - Be cautious with this - The MAs are inverted on the 3-month daily chart and the 20-day MA is now below the 50-day on the YTD weekly chart.
  • shoredriver: $SRPT still perky....
  • shoredriver: $SRPT....looking good in pre
  • shoredriver: @woodman $SRPT yeah, baby....
  • woodman: @shoredriver $SRPT - I bought some on Tuesday and - gulp - held it through earnings. Now, let the buyout speculation begin!
  • JBed: @woodman $SRPT I sold a third of my position yesterday going into earnings. Glad I held onto some!
  • shoredriver: @woodman $SRPT I bought mod position Wed....want to add....
  • woodman: @shoredriver $SRPT - well, that was good timing! Congrats
  • shoredriver: @woodman $SRPT does ease some of my other not so bright moves this week
  • JBed: @shoredriver $SRPT Kicking myself for not selling at the high today. Grrrr.
  • woodman: $SRPT - added.
  • JBed: $SRPT I'm nervous about earnings after hours - I should have sold my position at the high today (break-even) and now it's pulled back. I'll take a $120 loss if I sell but potentially -25% if I hold over earnings. Any ideas? I'm leaning towards taking the loss but also considering selling a covered call.
  • traderbren: @JBed $SRPT - I think it will hold up based on this news. FYI - Company anticipates net revenues for the year will exceed $95 million
  • justinp: $SRPT showing a tail on the day. Starting a small speculative position. Earnings AH tomorrow.
  • StockMarketMentor: A Price Alert has been triggered for $SRPT Sarepta Therapeutics Inc.. Click here to view associated video clip:
  • StockMarketMentor: A Price Alert has been triggered for $SRPT Sarepta Therapeutics Inc.. Click here to view associated video clip:
  • Aragorn: ...
    $SRPT hammer pattern above the 200 - Barron's article showing it some love today extended look fro any inside day or inside 60 as a signal if it breaks that candles high to take some or add
    Refiners are heating up with oil going down. These crackers ...
  • shoredriver: $SRPT....another one getting whacked...
  • orpheusredux: Highly speculative, but $SRPT looks like it's bottomed here. Will try a far-out in time call.
  • stevef214: @orpheusredux $SRPT As Chong would say on That 70's show, "Far out man" :)
  • tri2insite: @orpheusredux $SRPT Looks like support here but hasn't turned up yet. I've been in and out of this. ER 2/28.
  • orpheusredux: @champ $AAPL Closed call fly yesterday w/ >200% gain (woohoo). Kept JUN call spread. Similarly with $AGN closed call fly w/ small gain (stock running hard now) but kept ITM call spread. Still holding $REGN via call spread and will risk holding through earnings. Long $SRPT from $30 with stock. Risky, but it's been chopped in half.
  • orpheusredux: $AGN $SRPT $RGEN This is getting too easy. As soon as you hear Trump is meeting with the heads of your sector, you buy everything with buy hands. And your feet if you can. Happy $AGN and $SRPT (bought today) owner.
  • cmaxwel1: @orpheusredux $AGN $SRPT $RGEN (holding $AGN)
  • orpheusredux: This is a controversial name in a hated sector (right now), but I'm taking a small spec flyer on $SRPT via OTM out at least 3 mos (maybe longer) calls. Stock's been chopped in half. Having its first green day in over a week. Seems like downside is baked in and upside could be great.
  • orpheusredux: Hereby recanting my previous post on $SRPT. Stock behaving badly (again). Will wait and watch, but interested in eventually taking a small spec flyer on this in light of where it has fallen from and where it has the potential to go.
  • Rasta: $SRPT did a dirty to me just now. gapped down to $27 from $31 and hit my stop and then gapped back up to $37 with 10 minutes.
  • Rasta: @PJMR11 $SRPT are you still in? Good for you if your stop didn't hit.
  • jnag698: @Rasta $SRPT - Sorry to hear that. Down about 10% and bounce about 15 %? So a 10 pt swing? And they say that the HFT computers and their algos don't affect the market.
  • PJMR11: $LABU $SRPT I know stops are a good way to manage downsize risk but missing out of big 18% plus gains in an hour because stops went off is very frustrating
  • BocaRick: @PJMR11 $LABU $SRPT a lot of people use Price Alerts and then decide if they really want to sell.
  • PJMR11: @BocaRick $LABU $SRPT Couldn't meeting with a client at the time.
  • traderbren: $SRPT -- running RHRN
  • PJMR11: @traderbren $SRPT I could pout an end to the run by jumping back in but I will not do that to my fellow traders.
  • BocaRick: @PJMR11 $LABU $SRPT Yes, that job crap gets in the way of a lot of things. But, how often do you regret getting stopped out only to see the price climb back in the same day?
  • PJMR11: @BocaRick $LABU $SRPT True. However, I have been using Dan's 1% rule and that has worked out well, so I like to think that I would have been back in before the bulk of the run. Oh well, that is why they call it trading and not guaranteed money.
  • DrScience: @PJMR11 $SRPT Buying on a cross above the 200 DMA is good trading. And, placing a protective stop is prudent. But, assuming the 200 DMA would survive a retest may have been your undoing! So, let's look at some numbers and a strategy to see if you can ...
  • PJMR11: @DrScience $SRPT I have been away from my computer. Just saw this. Thank you for taking the time to give me your insights. That is why this is such a great forum. I am not as experienced as most here but I try to provide "heads up" when I see opportunities. Thanks again.
  • Bridget: ...
    $SRPT - short squeeze
    $WYNN - this channeling stock goes from ~$88- $104 and is now in the middle of the channel. Buy here for the move to $104
    $MASI and $NUVA - both medical supply companies reaching new highs. $MASI is the better choice
    $CCJ - ura ...
  • Rasta: Initiated starter position in $SRPT at $30. Came back to fill the gap from Sept 19 and now bouncing off 200dma
  • PJMR11: @Rasta $SRPT I am with you. Starter position at $29.97
  • Aragorn: $DXCM - went inside day and down the 21ema is firmly resistance for now $ ALXN is doing great went inside day and up. $SRPT bearish engulfing candle today
  • gwenzee: @debeers $UWTI $ULTA $MS $GS $MTZ $X $EOG $FDX $ODFL $MDVN $SRPT Please mention the fact that I got out of $SRPT @ $57 before the big self off.
  • Aragorn: @gwenzee $SRPT you just did and nicely done. Gwenzee that climactic run /parabolic ended once the 8ema was broken. It is such a useful tool, it has been a good trader as a short ever since. I have a few day trades short but better as short hold in hindsight. Oh ala Dan shortselling course, it came up to the 50 and was a re-short there.
  • debeers: @gwenzee $UWTI $ULTA $MS $GS $MTZ $X $EOG $FDX $ODFL $MDVN $SRPT --Yes you did, You told all of us to get out when you did and watched over all of us. Perhaps that was missed b y some.
  • debeers: ...
    IBB- What is this one--down about 20% for the year. So what if you picked $MDVN or $SRPT prior to the FDA decision and looked to Gwennie for these? Were you down then???

  • debeers: SRPT-Did I mention Gwen got us out prior to the sell off here? No? Well she did. So,the MDVN was up over 50% when I started learning about it and the $SRPT was up 30%. See? better than the IBB. Like Woodman, I swear off individual positions unless there is a compelling reason which usually involves my understanding them and their leg up on their competition. The first bio with ANY good news on Pancrestic Cancer, provided Gwen blesses it, I'm in as its been almost 20 years since there has been anything positive on this cancer.
  • issues: I just read a very encouraging article by Mike Brush (Brush Up On Stocks) from Market Watch: The article is entitled "MW 10 Biotechcompanies Ripe for Buyouts Courtesy of Donald Trump". There are lots of reasons why a Trump administration is going to push biotechs up higher. The list for buyouts includes $BIIB $INCY $TSRO $IONS $MDCO $ACAD as buyout candidates. Others mentioned included $BMRN $AZN.LN. Finally the article said that with Prop 61 failing in the most liberal state (Cal) that would have limited drug prices, the biotechs can price in increases. Also mentioned JNJ MRK PFE. Nov/Dec biggest for biotech all year. Companies with drugs that have minimal competition include: $VRTX $SRPT $CELG $ALXN. We own $VRTX$ IONS $CELG $ALXN and $IBB
  • orpheusredux: Look at those biotechs bucking the trend today! $ACAD up (WTF?!). $GILD up. $CELG up. $AMGN flat. $REGN up. $SRPT up. 'Course, how many days in a row could they go down? Still, nice to see some green somewhere!
  • woodman: $SRPT - Even with a good approval decision, now comes this decision by Anthem not to cover their drug. This is just so terrible for these families after all they went through to get it approved. The article calls it "tragic" and I can't think of a better word to describe it.
  • shoredriver: @woodman $SRPT agree totally
  • traderbren: @woodman $SRPT - totally agree.
  • osgood: @woodman $SRPT One can only wonder: why does health care have to be a for-profit industry?
  • osgood: @woodman $SRPT Too bad we don't have a czar of insurance saying, "Sorry Anthem, but you're picking this one up.'
  • shoredriver: @osgood $SRPT wow, well if you carry that thought out further then food, housing ,education, clothing and transportation should be the same....not sure I like that....
  • woodman: @osgood @shoredriver $SRPT - okay, okay, my post wasn't meant as an opportunity to turn this into political/social commentary. Let's just drop it now before it goes where it shouldn't. :-)
  • orpheusredux: Back in $SRPT with a JAN call fly with wide wings. Downside risk always exists, but it's held the 60 level convincingly enough to merit taking a shot at a leveraged gain if it stays in the 65-85 range till then.
  • orpheusredux: @woodman $CATB Hmmmm....veeeery interesting. I'm in $SRPT already but I may take some shares of this. Thanks.
Visit the Trading Forum to join in the discussion.
Stock Price $USD 93.48
Change 1.77%
Volume 1,372,070

Sarepta Therapeutics Inc discovers and develops RNA-based therapeutics for the treatment of rare and infectious diseases. Its lead product candidate is eteplirsen.

Request Video of SRPT
Already a member? Sign in here.


  • July 19th, 2018 - 2018 Q2 Earnings
Past Month

Leading Peers

Past Month

Lagging Peers

Dan Fitzpatrick

Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 14 day FREE membership. Get started TODAY and start trading better TOMORROW with the following premium content:

  • Nightly video Strategy Sessions with a game plan for tomorrow
  • Got a stock you want Dan to look at? Just ask.
  • Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
  • Access to over 55,600 stock analysis videos
  • Access an ever expanding library (55,600) of educational videos that will save you time and make you money

Join a team of friends and traders that have one thing in common; a burning desire to succeed.

Become a Member Today!

Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...

Satisfaction Guaranteed!

Your Stock Market Mentor membership comes with a 14 day, no questions asked, 100% money back guarantee!